Novel metal-binding proteins by design.

PubWeight™: 1.41‹?› | Rank: Top 5%

🔗 View Article (PMID 7664093)

Published in Nat Struct Biol on May 01, 1995

Authors

M Klemba1, K H Gardner, S Marino, N D Clarke, L Regan

Author Affiliations

1: Department of Molecular Biophysics & Biochemistry Yale University, New Haven, Connecticut 06520, USA.

Articles citing this

Enzyme-like proteins by computational design. Proc Natl Acad Sci U S A (2001) 3.43

Prediction of water and metal binding sites and their affinities by using the Fold-X force field. Proc Natl Acad Sci U S A (2005) 2.31

Automated design of the surface positions of protein helices. Protein Sci (1997) 2.26

Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination. Proc Natl Acad Sci U S A (1998) 1.39

Designing artificial enzymes by intuition and computation. Nat Chem (2009) 1.37

Coupling backbone flexibility and amino acid sequence selection in protein design. Protein Sci (1997) 1.25

Metal-mediated affinity and orientation specificity in a computationally designed protein homodimer. J Am Chem Soc (2011) 1.19

Protein design: toward functional metalloenzymes. Chem Rev (2014) 1.17

Development of bacterium-based heavy metal biosorbents: enhanced uptake of cadmium and mercury by Escherichia coli expressing a metal binding motif. Appl Environ Microbiol (1998) 1.10

Metalloprotein and metallo-DNA/RNAzyme design: current approaches, success measures, and future challenges. Inorg Chem (2006) 0.98

Soft metal ions, Cd(II) and Hg(II), induce triple-stranded alpha-helical assembly and folding of a de novo designed peptide in their trigonal geometries. Protein Sci (2000) 0.95

Staphylococcal surface display of metal-binding polyhistidyl peptides. Appl Environ Microbiol (2000) 0.95

Prediction of structures of zinc-binding proteins through explicit modeling of metal coordination geometry. Protein Sci (2010) 0.92

Designing hydrolytic zinc metalloenzymes. Biochemistry (2014) 0.91

The de novo design of a rubredoxin-like Fe site. Protein Sci (1998) 0.87

OptGraft: A computational procedure for transferring a binding site onto an existing protein scaffold. Protein Sci (2009) 0.87

Proteolytic enzymes, past and future. Proc Natl Acad Sci U S A (1999) 0.86

Generation of metal-binding staphylococci through surface display of combinatorially engineered cellulose-binding domains. Appl Environ Microbiol (2001) 0.80

Computational approaches for rational design of proteins with novel functionalities. Comput Struct Biotechnol J (2012) 0.78

Characterization of the functional role of Asp141, Asp194, and Asp464 residues in the Mn2+-L-malate binding of pigeon liver malic enzyme. Protein Sci (2000) 0.77

Using anchoring motifs for the computational design of protein-protein interactions. Biochem Soc Trans (2013) 0.76

Structural principles for computational and de novo design of 4Fe-4S metalloproteins. Biochim Biophys Acta (2015) 0.75

Metal Stabilization of Collagen and de Novo Designed Mimetic Peptides. Biochemistry (2015) 0.75

Probing the minimal determinants of zinc binding with computational protein design. Protein Eng Des Sel (2016) 0.75

Benchmarking a computational design method for the incorporation of metal ion-binding sites at symmetric protein interfaces. Protein Sci (2017) 0.75

Articles by these authors

(truncated to the top 100)

The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (1999) 12.60

Identification of the uvrA gene product. J Mol Biol (1981) 8.35

Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord (2001) 5.97

Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies) BMJ (1997) 4.54

Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature (1996) 4.25

A robust and cost-effective method for the production of Val, Leu, Ile (delta 1) methyl-protonated 15N-, 13C-, 2H-labeled proteins. J Biomol NMR (1999) 3.02

A thermodynamic scale for the beta-sheet forming tendencies of the amino acids. Biochemistry (1994) 2.98

The modern preventative treatment of recurrent miscarriage. Br J Obstet Gynaecol (1996) 2.90

Cost-effectiveness of magnetic resonance-guided focused ultrasound surgery for treatment of uterine fibroids. BJOG (2008) 2.89

Regulation of Hsp90 ATPase activity by tetratricopeptide repeat (TPR)-domain co-chaperones. EMBO J (1999) 2.71

An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod (1994) 2.38

Thrombophilia in pregnancy: a systematic review. Br J Haematol (2006) 2.33

Regulation of newly evolved enzymes. III Evolution of the ebg repressor during selection for enhanced lactase activity. Genetics (1977) 2.25

Protein alchemy: changing beta-sheet into alpha-helix. Nat Struct Biol (1997) 2.23

Prevalence of hepatitis C among pregnant women attending an inner London obstetric department: uptake and acceptability of named antenatal testing. Gut (2000) 2.19

Selective methyl group protonation of perdeuterated proteins. J Mol Biol (1996) 2.15

Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod (2008) 2.06

The risks associated with pregnancy in women aged 35 years or older. Hum Reprod (2000) 2.06

Modular arrangement of functional domains along the sequence of an aminoacyl tRNA synthetase. Nature (1984) 2.04

Pre-eclampsia, antiretroviral therapy, and immune reconstitution. Lancet (2002) 1.95

Identification of the uvrB gene product. J Mol Biol (1981) 1.92

Guidelines for protein design: the energetics of beta sheet side chain interactions. Science (1995) 1.88

Redesigning the hydrophobic core of a four-helix-bundle protein. Protein Sci (1994) 1.79

What makes a protein a protein? Hydrophobic core designs that specify stability and structural properties. Protein Sci (1996) 1.76

Solution NMR spectroscopy beyond 25 kDa. Curr Opin Struct Biol (1997) 1.73

Recurrent miscarriage. BMJ (1991) 1.72

A systematic exploration of the influence of the protein stability on amyloid fibril formation in vitro. Proc Natl Acad Sci U S A (2000) 1.70

Filters on the pathway to mental health care, II. Sociodemographic factors. Psychol Med (1995) 1.66

Relating functional changes during hand movement to clinical parameters in patients with multiple sclerosis in a multi-centre fMRI study. Eur J Neurol (2008) 1.63

Embryonic lethality and liver degeneration in mice lacking the metal-responsive transcriptional activator MTF-1. EMBO J (1998) 1.61

An inverse correlation between loop length and stability in a four-helix-bundle protein. Fold Des (1997) 1.57

Is maternal underweight really a risk factor for adverse pregnancy outcome? A population-based study in London. BJOG (2001) 1.53

Dissecting RNA-protein interactions: RNA-RNA recognition by Rop. Cell (1995) 1.53

Characterization of the structure and composition of gecko adhesive setae. J R Soc Interface (2006) 1.51

Cloning of Escherichia coli genes encoding 3-methyladenine DNA glycosylases I and II. Mol Gen Genet (1984) 1.51

Regulation of glycolysis in Lactococcus lactis: an unfinished systems biological case study. Syst Biol (Stevenage) (2006) 1.48

The C-terminal domain of the adenine-DNA glycosylase MutY confers specificity for 8-oxoguanine.adenine mispairs and may have evolved from MutT, an 8-oxo-dGTPase. Biochemistry (1999) 1.45

Factor V Leiden and recurrent miscarriage-prospective outcome of untreated pregnancies. Hum Reprod (2002) 1.42

Glucose production by the human placenta in vivo. Placenta (1999) 1.42

Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects. Clin Sci (Lond) (2002) 1.38

A tetrahedral zinc(II)-binding site introduced into a designed protein. Biochemistry (1990) 1.37

PAS kinase: an evolutionarily conserved PAS domain-regulated serine/threonine kinase. Proc Natl Acad Sci U S A (2001) 1.36

Multicriteria decision analysis: a comprehensive decision approach for management of contaminated sediments. Risk Anal (2006) 1.30

Identification of protein folds: matching hydrophobicity patterns of sequence sets with solvent accessibility patterns of known structures. Proteins (1990) 1.29

Dispensable pieces of an aminoacyl tRNA synthetase which activate the catalytic site. Cell (1984) 1.28

Future pregnancy outcome in unexplained recurrent first trimester miscarriage. Hum Reprod (1997) 1.28

Obstetric risks of pregnancy in women less than 18 years old. Obstet Gynecol (2000) 1.27

Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas. Ultrasound Obstet Gynecol (2009) 1.27

Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess (2006) 1.27

Dramatic structural and thermodynamic consequences of repacking a protein's hydrophobic core. Structure (2000) 1.27

Association of bacterial vaginosis with a history of second trimester miscarriage. Hum Reprod (1996) 1.26

Amino-acid substitutions in a surface turn modulate protein stability. Nat Struct Biol (1996) 1.22

Refinement of the structure of beta-chitin. Biopolymers (1975) 1.21

Gonadotrophin-releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata. Obstet Gynecol (2006) 1.20

Reproductive outcomes in women with congenital uterine anomalies detected by three-dimensional ultrasound screening. Obstet Gynecol (2001) 1.19

Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas. Oncogene (2010) 1.19

Magnetic resonance guided focused ultrasound surgery of uterine fibroids--the tissue effects of GnRH agonist pre-treatment. Eur J Radiol (2006) 1.18

A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Hum Reprod (2004) 1.16

Transmuting alpha helices and beta sheets. Fold Des (1997) 1.15

Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization. Fertil Steril (2000) 1.13

Sidechain interactions in parallel beta sheets: the energetics of cross-strand pairings. Structure (1999) 1.13

The plug domain of FepA, a TonB-dependent transport protein from Escherichia coli, binds its siderophore in the absence of the transmembrane barrel domain. Proc Natl Acad Sci U S A (2001) 1.12

Computer search algorithms in protein modification and design. Curr Opin Struct Biol (1998) 1.12

Propylthiouracil tasting: determination of underlying threshold distributions using maximum likelihood. Chem Senses (1995) 1.11

Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod (1999) 1.10

Surface point mutations that significantly alter the structure and stability of a protein's denatured state. Protein Sci (1996) 1.09

A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J Neuropathol Exp Neurol (1994) 1.07

Effect of tumour necrosis factor-alpha and interleukin 1beta on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro. Br J Pharmacol (2003) 1.06

Recurrent miscarriage and variant alleles of mannose binding lectin, tumour necrosis factor and lymphotoxin alpha genes. Clin Exp Immunol (2001) 1.05

Factor V Leiden and acquired activated protein C resistance among 1000 women with recurrent miscarriage. Hum Reprod (2001) 1.05

Effect of alteration of the acetic acid synthesis pathway on the fermentation pattern of escherichia coli. Biotechnol Bioeng (1991) 1.05

The role of backbone conformational heat capacity in protein stability: temperature dependent dynamics of the B1 domain of Streptococcal protein G. Protein Sci (2000) 1.04

Recurrent miscarriage--an aspirin a day? Hum Reprod (2000) 1.04

Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition. Exp Brain Res (2008) 1.04

Understanding the sequence determinants of conformational switching using protein design. Protein Sci (2000) 1.04

Specific recognition of A/G and A/7,8-dihydro-8-oxoguanine (8-oxoG) mismatches by Escherichia coli MutY: removal of the C-terminal domain preferentially affects A/8-oxoG recognition. Biochemistry (1996) 1.03

Simplified surveillance for nosocomial bloodstream infections. Infect Control Hosp Epidemiol (1998) 1.03

Polypeptide sequences essential for RNA recognition by an enzyme. Science (1987) 1.02

Reengineering granulocyte colony-stimulating factor for enhanced stability. J Biol Chem (2001) 1.01

Stability, efficacy, and safety of continuously infused sucrose-formulated recombinant factor VIII (rFVIII-FS) during surgery in patients with severe haemophilia. Haemophilia (2009) 1.01

Aberrations of early trophoblast differentiation predispose to pregnancy failure: lessons from the anti-phospholipid syndrome. Placenta (2005) 1.01

Aromatic rescue of glycine in beta sheets. Fold Des (1998) 0.99

Characterization of metal binding by a designed protein: single ligand substitutions at a tetrahedral Cys2His2 site. Biochemistry (1995) 0.99

Efficacies of two new antifungal agents, the triazole ravuconazole and the echinocandin LY-303366, in an experimental model of invasive aspergillosis. Antimicrob Agents Chemother (2000) 0.99

Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod (2002) 0.98

Reproducibility of fMRI in the clinical setting: implications for trial designs. Neuroimage (2008) 0.98

Comparison of five commercial serological tests for the detection of anti-Chlamydia trachomatis antibodies. Eur J Clin Microbiol Infect Dis (2010) 0.97

Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol (1999) 0.96

Genetic thrombophilic mutations among couples with recurrent miscarriage. Hum Reprod (2006) 0.95

Inhibition of spontaneous receptor phosphorylation by residues in a putative alpha-helix in the KIT intracellular juxtamembrane region. J Biol Chem (1999) 0.95

A further look at infection at the time of therapeutic abortion. Eur J Obstet Gynecol Reprod Biol (1990) 0.95

Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod (2000) 0.95

Reproducibility of three-dimensional ultrasound diagnosis of congenital uterine anomalies. Ultrasound Obstet Gynecol (2003) 0.95

Solution structure of a DNA dodecamer containing the anti-neoplastic agent arabinosylcytosine: combined use of NMR, restrained molecular dynamics, and full relaxation matrix refinement. Biochemistry (1994) 0.95

A comparative study of the morphology of congenital uterine anomalies in women with and without a history of recurrent first trimester miscarriage. Hum Reprod (2003) 0.95

High prospective fetal loss rate in untreated pregnancies of women with recurrent miscarriage and antiphospholipid antibodies. Hum Reprod (1995) 0.94

A chimeric protein C containing the prothrombin Gla domain exhibits increased anticoagulant activity and altered phospholipid specificity. J Biol Chem (1998) 0.94

Tumor cell proliferation and apoptosis in medulloblastoma. Acta Neuropathol (1994) 0.94

Bmi1 directly represses p21Waf1/Cip1 in Shh-induced proliferation of cerebellar granule cell progenitors. Mol Cell Neurosci (2010) 0.92

Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod (1995) 0.92